Longitudinal stability of CSF tau levels in Alzheimer patients

被引:84
作者
Sunderland, T
Wolozin, B
Galasko, D
Levy, J
Dukoff, R
Bahro, M
Lasser, R
Motter, R
Lehtimäki, T
Seubert, P
机构
[1] NIMH, Ctr Clin, Geriatr Psychiat Branch, NIH, Bethesda, MD 20892 USA
[2] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA
[3] Tampere Univ, Dept Clin Chem, FIN-33101 Tampere, Finland
[4] Athena Neurosci Inc, San Francisco, CA USA
关键词
cerebrospinal fluid; tau; dementia; surrogate marker;
D O I
10.1016/S0006-3223(99)00143-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Antemortem levels of tau in the cerebrospinal fluid (CSF) of Alzheimer's disease (RD) patients have: repeatedly been demonstrated to be elevated when compared to controls. Although CSF tau has been reported to be elevated even in very mild AD, it is unknown how tau levels change during the course of the disease. Methods: We have followed 29 mild-to-moderately affected AD subjects over 2 years with repeated CSF taps. Clinical measures of dementia severity (Clinical Dementia Rating Scale, Global Deterioration Scale and Mini-Mental Status Examination) were obtained at the start and conclusion of the observation period, and CSF tau was measured with a standard enzyme-linked immunoabsorbent assay (ELISA) using two monoclonal antibodies. Results: Despite significant changes in the clinical measures consistent with progression of the disease, no significant overall change in CSF tau levels (548 +/- 355 vs. 557 +/- 275 pg/mL, NS) was observed None of the clinical variables was significantly correlated with either baseline measures of CSI; tau or delta CSF tau (last-first). Similarly, CSF tau at baseline and changes over time were not significantly related to Apolipoprotein E (APO E) phenotype. Conclusions: These data suggest that CSF tau levels are stable over extended periods of time in a group of mild-to-moderately demented AD subjects and that CSF tau levels do not predict the severity or rate of progression of AD, at least not during the middle stages of the illness.
引用
收藏
页码:750 / 755
页数:6
相关论文
共 46 条
  • [31] ANTISENSE STRATEGY UNRAVELS TAU-PROTEINS AS MOLECULAR RISK-FACTORS FOR GLUTAMATE-INDUCED NEURODEGENERATION
    PIZZI, M
    VALERIO, A
    ARRIGHI, V
    BELLONI, M
    ALBERICI, A
    SPANO, PF
    MEMO, M
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 1994, 14 (05) : 569 - 578
  • [32] INHIBITION OF GLUTAMATE-INDUCED NEUROTOXICITY BY A TAU ANTISENSE OLIGONUCLEOTIDE IN PRIMARY CULTURE OF RAT CEREBELLAR GRANULE CELLS
    PIZZI, M
    VALERIO, A
    ARRIGHI, V
    GALLI, P
    BELLONI, M
    RIBOLA, M
    ALBERICI, A
    SPANO, P
    MEMO, M
    [J]. EUROPEAN JOURNAL OF NEUROSCIENCE, 1995, 7 (07) : 1603 - 1613
  • [33] REISBERG B, 1982, AM J PSYCHIAT, V139, P1136
  • [34] Cerebrospinal protein tau is elevated in early Alzheimer's disease
    Riemenschneider, M
    Buch, K
    Schmolke, M
    Kurz, A
    Guder, WG
    [J]. NEUROSCIENCE LETTERS, 1996, 212 (03) : 209 - 211
  • [35] CLINICAL CORRELATES OF CORTICAL AND NUCLEUS BASALIS PATHOLOGY IN ALZHEIMER DEMENTIA
    SAMUEL, W
    TERRY, RD
    DETERESA, R
    BUTTERS, N
    MASLIAH, E
    [J]. ARCHIVES OF NEUROLOGY, 1994, 51 (08) : 772 - 778
  • [36] SKOOG I, 1996, NEUROSCI LETT, V214, P163
  • [37] APOLIPOPROTEIN-E - HIGH-AVIDITY BINDING TO BETA-AMYLOID AND INCREASED FREQUENCY OF TYPE-4 ALLELE IN LATE-ONSET FAMILIAL ALZHEIMER-DISEASE
    STRITTMATTER, WJ
    SAUNDERS, AM
    SCHMECHEL, D
    PERICAKVANCE, M
    ENGHILD, J
    SALVESEN, GS
    ROSES, AD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (05) : 1977 - 1981
  • [38] The level of cerebrospinal fluid tau correlates with neurofibrillary tangles in Alzheimer's disease
    Tapiola, T
    Overmyer, M
    Lehtovirta, M
    Helisalmi, S
    Ramberg, J
    Alafuzoff, I
    Riekkinen, P
    Soininen, H
    [J]. NEUROREPORT, 1997, 8 (18) : 3961 - 3963
  • [39] TAU-PROTEIN CONCENTRATIONS IN CEREBROSPINAL-FLUID OF PATIENTS WITH DEMENTIA OF THE ALZHEIMER-TYPE
    TATO, RE
    FRANK, A
    HERNANZ, A
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1995, 59 (03) : 280 - 283
  • [40] TERRY RD, 1987, J NEUROPATHOL EXP NE, V46, P2262